Institut Curie

Research facility


Location: Paris, France (FR) FR

ISNI: 0000000406396384

ROR: https://ror.org/04t0gwh46

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility (2018) Machiela MJ, Gruenewald TGP, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, et al. Conference contribution Multiple new susceptibility loci identified in genome-wide association study of Ewing sarcoma (2018) Machiela MJ, Gruenewald TG, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, et al. Conference contribution Selumetinib in combination with dacarbazine in patients with metastatic uveal melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT) (2018) Carvajal RD, Piperno-Neumann S, Kapiteijn E, Chapman PB, Frank S, Joshua AM, Piulats JM, et al. Journal article Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial (2018) Ignatiadis M, Litiere S, Rothe F, Riethdorf S, Proudhon C, Fehma T, Aalders K, et al. Journal article Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility (2018) Machiela MJ, Grunewald TGP, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, et al. Journal article Topological defects in epithelia govern cell death and extrusion (2017) Saw TB, Doostmohammadi A, Nier V, Kocgozlu L, Thampi S, Toyama Y, Marcq P, et al. Journal article Contractile forces at tricellular contacts modulate epithelial organization and monolayer integrity (2017) Salomon J, Gaston C, Magescas J, Duvauchelle B, Canioni D, Sengmanivong L, Mayeux A, et al. Journal article Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study (2017) Higgins M, Curigliano G, Dieras V, Kuemmel S, Kunz G, Fasching P, Campone M, et al. Journal article BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer (2017) Shimelis H, Mesman RLS, Von Nicolai C, Ehlen A, Guidugli L, Martin C, Calleja FMGR, et al. Journal article Runx2 mediated Induction of Novel Targets ST2 and Runx3 Leads to Cooperative Regulation of Hypertrophic Differentiation in ATDC5 Chondrocytes (2017) Rad EB, Musumeci G, Pichler K, Heidary M, Szychlinska MA, Castrogiovanni P, Marth E, et al. Journal article
1 ... 4 5 6 7 8